glp 1 or sglt2 Inhibitors and GLP-1 Receptor Agonists in Kidney Transplantation: A Systematic Review and Meta-Analysis SGLT2 Inhibitors and GLP-1 Receptor
Description
Prescribed if clinically appropriate
The booming GLP-1 market, projected to reach $167bn by 2031, presents compelling opportunities for private equity players to carve out their niche and capture substantial value, despite industry giants Novo Nordisk and Eli Lilly dominating the lions share of the market. Download PDF
Additionally, GLP-1R agonists reduce visceral hypersensitivity and ameliorate symptoms in patients with irritable bowel syndrome
Paired with Chromium Picolinate, it helps curb cravings for sugary, high-fat, and carb-loaded foods
